Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
16
-
Total 13F shares, excl. options
-
4,123,869
-
Shares change
-
-894,565
-
Total reported value, excl. options
-
$19,671,000
-
Value change
-
+$24,031
-
Number of buys
-
9
-
Number of sells
-
10
-
Price
-
$4.77
Institutional Holders of ZOSANO PHARMA CORP - COM NEW (ZSAN) as of Q1 2019
As of 31 Mar 2019 ZOSANO PHARMA CORP - COM NEW (ZSAN) had 16 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 4,123,869 shares of stock of the company.
Largest 10 holders included Aisling Capital Management LP, ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC, BlackRock Inc., MORGAN STANLEY, Telemetry Investments, L.L.C., GEODE CAPITAL MANAGEMENT, LLC, MYDA Advisors LLC, DIMENSIONAL FUND ADVISORS LP, and UBS Group AG.
This table shows 16 institutional shareholders of the security as of 31 Mar 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.